FIVE PRIME THERAPEUTICS INC - COM (FPRX)

CUSIP: 33830X104

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class
Equity / COM
Total 13F shares
31,018,077
Share change
-1,371,722
Total reported value
$490,373,222
Put/Call ratio
54%
Price per share
$15.81
Number of holders
118
Value change
-$25,262,322
Number of buys
66
Number of sells
55

Quarterly Holders Quick Answers

What is CUSIP 33830X104?
CUSIP 33830X104 identifies FPRX - FIVE PRIME THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FIVE PRIME THERAPEUTICS INC - COM (FPRX) as of Q2 2018

As of 30 Jun 2018, FIVE PRIME THERAPEUTICS INC - COM (FPRX) was held by 118 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 31,018,077 shares. The largest 10 holders included FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, GREAT POINT PARTNERS LLC, DIMENSIONAL FUND ADVISORS LP, BVF INC/IL, VICTORY CAPITAL MANAGEMENT INC, and PRICE T ROWE ASSOCIATES INC /MD/. This page lists 118 institutional shareholders reporting positions in this security for the Q2 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.